Chemistry - An Asian Journal
10.1002/asia.201500266
3453-3459; c) Y. Abe, H. Kayakiri, S. Satoh, T. Inoue, Y. Sawada, K. Imai, N.
Inamura, M. Asano, C. Hatori, A. Katayama, T. Oku, H. Tanaka, J. Med. Chem.
1998, 41, 564-578; d) M. Lhassani, O. Chavignon, J. M. Chezal, J. C. Teulade,
J. P. Chapat, R. Snoeck, G. Andrei, J.; Balzarini, E. De Clercq, A. Gueiffier,
Eur. J. Med. Chem. 1999, 34, 271-274; e) K. C. Rupert, J. R. Henry, J. H. Dodd,
S. A. Wadsworth, D. E. Cavender, G. C. Olini, B. Fahmy, J. J. Siekierka,
Bioorg. Med. Chem. Lett. 2003, 13, 347-350; f) R. Ducray, C. D. Jones, F. H.
Jung, I. Simpson, J. Curwen, M. Pass, Bioorg. Med. Chem. Lett. 2011, 21,
4702-4704; g) R. Ducray, I. Simpson, F. H. Jung, W. M. Nissink, P. W. Kenny,
M. Fitzek, G. E. Walker, L. T. Ward, K. Hudson, Bioorg. Med. Chem. Lett.
2011, 21, 4698-4701; h) C. M. Marson, Chem. Soc. Rev. 2011, 40, 5514-5533.
In summary, we have developed a novel methodology for the
synthesis of pyrido[2',1':2,3]imidazo[4,5-c]quinolines through
one-pot sequential reactions of commercially available or readily
obtainable 2-aminopyridines, 2-bromophenacyl bromides,
aqueous ammonia and aldehydes. Substrate generality studies
showed that this novel process provided a facile route to access a
class of tetracyclic heterocylces with good structural diversity.
Moreover, dihydropyrido[2',1':2,3]imidazo[4,5-c]quinolines could
also be obtained in a similar manner by using various ketones as
the substrates in place of aldehydes. Notably, the whole procedure
combines condensation/amination/cyclization reactions in one-pot
to give complex compounds in a simple and practical manner.
Compared with literature methods, the synthetic strategy reported
herein has the advantages of readily available starting materials,
structural diversity of products, good functional group tolerance,
and obviation of step by step operations.
[4] a) A. Elhakmaoui, A. Gueiffier, J. C. Milhavet, Y. Blache, J. P. Chapat, O. C.
Chavignon, J. Teulade, R. Snoeck, G. Andrei, E. De Clercq, Bioorg. Med. Chem.
Lett. 1994, 4, 1937-1940; b) Y. Abe, H. Kayakiri, S. Satoh, T. Inoue, Y. Sawada,
N. Inamura, M. Asano, I. Aramori, C. Hatori, H. Sawai, T. Oku, H. Tanaka, J.
Med. Chem. 1998, 41, 4587-4598; c) T. Okubo, R. Yoshikawa, S. Chaki, S.
Okuyama, A. Nakazato, Bioorg. Med. Chem. 2004, 12, 423-438; e) N. Shao, G.
X. Pang, C. X. Yan, G. F. Shi, Y. Cheng, J .Org. Chem. 2011, 76, 7458-7465.
[5] a) R. B. Lacerda, C. K. de Lima, L. L. da Silva, N. C. Romeiro, A. L. Miranda,
E. J. Barreiro, C. A. Fraga, Bioorg. Med. Chem. 2009, 17, 74-84; b) O. Kim, Y.
Jeong, H. Lee, S.-S. Hong, S. Hong, J. Med. Chem. 2011, 54, 2455-2466.
Experimental Section
General procedure for the preparation of pyrido[2',1':2,3]imidazo[4,5-c]
quinolines (5).
[6] a) K. S. Gudmundsson, J. D. Williams, J. C. Drach, L. B. Townsend, J. Med.
Chem. 2003, 46, 1449-1455; b) N. M. Shukla, D. B. Salunke, E. Yoo, C. A.
Mutz, R. Balakrishna, S. A. David, Bioorg. Med. Chem. 2012, 20, 5850-5863; c)
T. H. Al-Tel, R. A. Al-Qawasmeh, R. Zaarour, Eur. J. Med. Chem. 2011, 46,
1874-1881; d) M. A. Ismail, R. K. Arafa, T. Wenzler, R. Brun, F. A. Tanious,
W. D. Wilson, D. W. Boykin, Bioorg. Med. Chem. 2008, 16, 683-691.
To a tube containing a solution of 2-aminopyridine (0.5 mmol) and 2-bromophenacyl
bromide (0.5 mmol) in DMF (2 mL) was added K3PO4·3H2O (0.6 mmol). It was then
stirred at 80 oC for 4 h. Next, CuI (0.1 mmol), 1,10-phen (0.1 mmol) and aqueous
ammonia (26%, 0.5 mL) were added. The tube was sealed and the mixture was
stirred at 80 oC for 8 h. After the pH value of the resulting mixture was adjusted to a
range of 4~5 by dropwise addition of HCl (36%), aldehyde (0.5 mmol) was added. It
was then stirred at 80 °C under air for another 4 h. Upon completion, the reaction
was quenched with water and extracted with ethyl acetate (10 mL × 3). The
combined organic layer was washed with H2O and brine, and then dried over
anhydrous Na2SO4. The solvent was evaporated under vacuum and the crude product
was purified by chromatography on silica-gel (petroleum ether/ethyl acetate = 3:1) to
afford pyrido[2',1':2,3]imidazo[4,5-c]quinolines (5).
[7] a) M. Arnould, M.-A. Hiebel, S. Massip, J. M. Léger, C. Jarry, S. Berteina-
Raboin, G. Cuillaumet, Chem. Eur. J. 2013, 19, 12249-12253; b) S. Sharma, B.
Saha, D. Sawant, B. Kundu, J. Comb. Chem. 2007, 9, 783-792; c) T. Meng, Z.
X. Zhang, D. Y. Hu, L. P. Lin, J. Ding, X. Wang, J. K. Shen, J. Comb. Chem.
2007, 9, 739-741; d) K. Pericherla, A. Jha, B. Khungar, A. Kumar. Org. Lett.
2013, 15, 4304-4307.
[8] M. Romero, P. Renard, D.-H. Caignard, G. Atassi, X. Solans, P. Constans, C.
Bailly, M. D. Pujol, J. Med. Chem. 2007, 50, 294-307.
[9] a) A. Dömling, Chem. Rev. 2006, 106, 17-89; b) B. B. Touré, D. G. Hall, Chem.
Rev. 2009, 109, 4439-4486; c) A. Shaabani, A. Maleki, A. H. Rezayan, A.
Sarvary, Mol. Divers. 2011, 15, 41-68; d) C. M. Volla, I. Atodiresei, M.
Rueping, Chem. Rev. 2014, 114, 2390-2431.
General procedure for the preparation of 5,6-dihydropyrido[2',1':2,3]imidazo
[4,5-c]quinolines (7).
To a tube containing a solution of 2-aminopyridine (0.5 mmol) and 2-bromophenacyl
bromide (0.5 mmol) in DMF (2 mL) was added K3PO4·3H2O (0.6 mmol). It was then
stirred at 80 oC for 4 h. Next, CuI (0.1 mmol), 1,10-phen (0.1 mmol) and aqueous
ammonia (26%, 0.5 mL) were added. The tube was sealed and the mixture was
stirred at 80 oC for 8 h. After the pH value of the resulting mixture was adjusted to a
range of 4~5 by dropwise addition of HCl (36%), ketone (0.5 mmol) was added. It
was then stirred at 80 °C under a nitrogen atmosphere for another 4 h. Upon
completion, the reaction was quenched with water and extracted with ethyl acetate
(10 mL×3). The combined organic layer was washed with H2O and brine, and then
dried over anhydrous Na2SO4. The solvent was evaporated under vacuum and the
crude product was purified by chromatography on silica-gel (dichloromethane/
methanol = 100:1) to afford 5,6-dihydropyrido[2',1':2,3]imidazo[4,5-c]quinolines (7).
[10] a) H. H. Nguyen, T. A. Palazzo, M. J. Kurth, Org. Lett. 2013, 15, 4492-4495; b)
P. Salehi, D. I. MaGee, M. Dabiri, L. Torkian, J. Donahue, Mol. Divers. 2012,
16, 231-240; c) C. Che, S. Li, Z. Yu, F. Li, S. Xin, L. Zhou, S. Lin, Z. Yang,
ACS Comb. Sci. 2013, 15, 202-207.
[11] a) D. Ma, Q. Cai, Acc. Chem. Res. 2008, 41, 1450-1460; b) G. Evano, N.
Blanchard, M. Toumi, Chem. Rev. 2008, 108, 3054-3131; c) Y. Liu, J.-P. Wan,
Org. Biomol. Chem. 2011, 9, 6873-6894; d) C. Zhang, C. Tang, N. Jiao, Chem.
Soc. Rev. 2012, 41, 3464-3484; e) I. P. Beletskaya, A. V. Cheprakov,
Organometallics 2012, 31, 7753-7808; f) Y. Liu, J.-P. Wan, Chem. Asian J.
2012, 7, 1488-1501.
[12] a) T. Liu, H. Fu, Synthesis 2012, 2805-2824; b) P. Sang, Y. Xie, J. Zou, Y.
Zhang, Org. Lett. 2012, 14, 3894-3897; c) Y. Lv, Y. Li, T. Xiong, W. Pu, H.
Zhang, K. Sun, Q. Liu, Q. Zhang, Chem. Commun. 2013, 49, 6439-6441; d) P.
Sang, M. Yu, H. Tu, J. Zou, Y. Zhang, Chem. Commun. 2013, 49, 701-703.
Acknowledgements
We are grateful to the National Natural Science Foundation of China (NSFC) (grant
numbers 21272058, 21172057), Program for Innovative Research Team in Science
and Technology in University of Henan Province (15IRTSTHN003), Program for
Science and Technology Innovation Talents in Universities of Henan Province
(15HASTIT005), and PCSIRT (IRT 1061) for financial support.
[13] a) J. Zhang, C. Yu, S. Yang, C. Wan, Z. Wang, Chem. Commun. 2010, 46,
5244-5246; b) Y. Ohta, Y. Tokimizu, S. Oishi, N. Fujii, H. Ohno, Org. Lett.
2010, 12, 3963-3965; c) Z. Wang, F. Yang, X. Lv, W. Bao, J. Org. Chem. 2011,
76, 967-970; d) H. Zhang, Y. Jin, H. Liu, Y. Jiang, H. Fu, Eur. J. Org. Chem.
2012, 6798-6803.
Keywords: Pyrido[2',1':2,3]imidazo[4,5-c]quinolines • 5,6-
dihydropyrido[2',1':2,3]imidazo[4,5-c]quinolines • copper
catalysis • one-pot sequential reaction • amination
[14] a) S. Guo, J. Wang, X. Fan, X. Zhang, D. Guo, J. Org. Chem. 2013, 78, 3262-
3270; b) X. Fan, B. Li, S. Guo, Y. Wang, X. Zhang, Chem. Asian J. 2014, 9,
739-743; c) X. Zhang, X. Guo, X. Fan, Chem. Asian J. 2015, 10, 106-111; d) B.
Li, C. Guo, X. Fan, J. Zhang, X. Zhang, Tetrahedron Lett. 2014, 55, 5944-5948.
e) S. Guo, Y. Li, L, Tao, W. Zhang, X. Fan, RSC Adv. 2014, 4, 59289-59296.
[1] a) A. T. Balaban, D. C. Oniciu, A. R. Katritzky, Chem. Rev. 2004, 104, 2777-
2812; b) N. R. Candeias, L. C. Branco, P. M. P. Gois, C. A. M. Afonso, A. F.
Trindade, Chem. Rev. 2009, 109, 2703-2802; c) L. Zhang, X.-M. Peng, G. L. V.
Damu, R.-X. Geng, C.-H. Zhou, Med. Res. Rev. 2014, 34, 340-437.
[2] C. Enguehard-Gueiffier, A. Gueiffier, Mini-Rev. Med. Chem. 2007, 7, 888-892.
Received:
Revised:
Published online:
[3] a) Y. Rival, G. Grassy, G. Michel, Chem. Pharm. Bull. 1992, 40, 1170-1176; b)
K. S. Gudmundsson, J. C. Drach, L. B. Townsend, J. Org. Chem. 1997, 62,
4